Open for inclusion

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Trial of Crenolanib in Subjects with Advanced or Metastatic Gastrointestinal Stromal Tumors with a D842V Mutation in the PDGFRA Gene

Cancer type: Sarcoma

Phase: II

Principal Investigator: Hall Sundby Kirsten

Country: NO

Keywords: Norway, Oslo, GIST, crenolanib

Status: Open for inclusion

Link to